276 related articles for article (PubMed ID: 25505186)
1. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.
Wang X; Gray MC; Hewlett EL; Maynard JA
J Biol Chem; 2015 Feb; 290(6):3576-91. PubMed ID: 25505186
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes.
Goldsmith JA; DiVenere AM; Maynard JA; McLellan JS
PLoS Pathog; 2021 Sep; 17(9):e1009920. PubMed ID: 34547035
[TBL] [Abstract][Full Text] [Related]
3. Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.
Wang X; Stapleton JA; Klesmith JR; Hewlett EL; Whitehead TA; Maynard JA
Biochemistry; 2017 Mar; 56(9):1324-1336. PubMed ID: 28177609
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
5. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
[No Abstract] [Full Text] [Related]
6. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.
Betsou F; Sebo P; Guiso N
Infect Immun; 1995 Sep; 63(9):3309-15. PubMed ID: 7642260
[TBL] [Abstract][Full Text] [Related]
7. Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin.
Espinosa-Vinals CA; Masin J; Holubova J; Stanek O; Jurnecka D; Osicka R; Sebo P; Bumba L
J Biol Chem; 2021 Jul; 297(1):100833. PubMed ID: 34051233
[TBL] [Abstract][Full Text] [Related]
8. Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of
Masin J; Osickova A; Jurnecka D; Klimova N; Khaliq H; Sebo P; Osicka R
J Biol Chem; 2020 Jul; 295(28):9349-9365. PubMed ID: 32393579
[TBL] [Abstract][Full Text] [Related]
9. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A activity of adenylate cyclase toxin mediates translocation of its adenylate cyclase domain.
González-Bullón D; Uribe KB; Martín C; Ostolaza H
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6784-E6793. PubMed ID: 28760979
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
Lee SJ; Gray MC; Guo L; Sebo P; Hewlett EL
Infect Immun; 1999 May; 67(5):2090-5. PubMed ID: 10225859
[TBL] [Abstract][Full Text] [Related]
12. Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of
Holubova J; Juhasz A; Masin J; Stanek O; Jurnecka D; Osickova A; Sebo P; Osicka R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769101
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis.
Skopova K; Tomalova B; Kanchev I; Rossmann P; Svedova M; Adkins I; Bibova I; Tomala J; Masin J; Guiso N; Osicka R; Sedlacek R; Kovar M; Sebo P
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322
[TBL] [Abstract][Full Text] [Related]
14. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.
Boyd AP; Ross PJ; Conroy H; Mahon N; Lavelle EC; Mills KH
J Immunol; 2005 Jul; 175(2):730-8. PubMed ID: 16002668
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
Orr B; Douce G; Baillie S; Parton R; Coote J
Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
[TBL] [Abstract][Full Text] [Related]
17. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
Khosravani A; Parker MC; Parton R; Coote J
Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
Arciniega JL; Hewlett EL; Edwards KM; Burns DL
FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
[TBL] [Abstract][Full Text] [Related]
19. Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen.
Malik AA; Imtong C; Sookrung N; Katzenmeier G; Chaicumpa W; Angsuthanasombat C
Toxins (Basel); 2016 Apr; 8(4):99. PubMed ID: 27043627
[TBL] [Abstract][Full Text] [Related]
20. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
Simsova M; Sebo P; Leclerc C
Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
